Trial Outcomes & Findings for Impact on Management of the HEART Risk Score in Chest Pain Patients (NCT NCT01756846)
NCT ID: NCT01756846
Last Updated: 2019-01-25
Results Overview
occurrence of major adverse cardiac events (MACE, i.e. acute myocardial infarction (AMI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG) or death) within 6 weeks after presentation
COMPLETED
NA
3666 participants
6 weeks
2019-01-25
Participant Flow
Inclusion at 9 Dutch Emergency departments, recruitment period between 1-7-2013 and 31-8-2014.
Exclusion criteria were evident ST-segment elevation myocardial infarction, language barriers, recurrent presentation, or unable or unwilling to give informed consent.
Participant milestones
| Measure |
Usual Care
usual care was defined as daily practice of the cardiologist or attending emergency doctor, in order to diagnose a patient with chest pain. In this period attending doctors assess the risk of a patient with chest pain, based on his/hers experience and various criteria (for example described in European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, without a formal risk score).
|
HEART Care
HEART care: usual care, complemented by calculation of the HEART score and following the recommended policy.
During 14 months, patients presenting with chest pain to the emergency department (ED) of participating hospitals were included in the study. First, all hospitals applied 'usual care' to all patients, i.e. risk assessment and subsequent management without application of the HEART score. Then, during a 14 month period, each 1,5 month 1 randomly allocated hospital sequentially started to apply the HEART score in all chest pain patients (intervention period); during this intervention period patients with a HEART score 0-3 were advised not be admitted to the hospital, and patients with a HEART score above 3 were advised to be treated according to current guidelines.
|
|---|---|---|
|
Overall Study
STARTED
|
1833
|
1833
|
|
Overall Study
COMPLETED
|
1827
|
1821
|
|
Overall Study
NOT COMPLETED
|
6
|
12
|
Reasons for withdrawal
| Measure |
Usual Care
usual care was defined as daily practice of the cardiologist or attending emergency doctor, in order to diagnose a patient with chest pain. In this period attending doctors assess the risk of a patient with chest pain, based on his/hers experience and various criteria (for example described in European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, without a formal risk score).
|
HEART Care
HEART care: usual care, complemented by calculation of the HEART score and following the recommended policy.
During 14 months, patients presenting with chest pain to the emergency department (ED) of participating hospitals were included in the study. First, all hospitals applied 'usual care' to all patients, i.e. risk assessment and subsequent management without application of the HEART score. Then, during a 14 month period, each 1,5 month 1 randomly allocated hospital sequentially started to apply the HEART score in all chest pain patients (intervention period); during this intervention period patients with a HEART score 0-3 were advised not be admitted to the hospital, and patients with a HEART score above 3 were advised to be treated according to current guidelines.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
5
|
10
|
|
Overall Study
Withdrawal by Subject
|
1
|
2
|
Baseline Characteristics
Impact on Management of the HEART Risk Score in Chest Pain Patients
Baseline characteristics by cohort
| Measure |
Usual Care
n=1827 Participants
standard care of the cardiologist according to current cardiological guidelines
|
HEART Care
n=1821 Participants
standard care of the cardiologist according to current cardiological guidelines, complemented by calculation of the HEART score and following the recommended policy
|
Total
n=3648 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
62 years
STANDARD_DEVIATION 14 • n=5 Participants
|
62 years
STANDARD_DEVIATION 14 • n=7 Participants
|
62 years
STANDARD_DEVIATION 14 • n=5 Participants
|
|
Sex: Female, Male
Female
|
822 Participants
n=5 Participants
|
846 Participants
n=7 Participants
|
1668 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1005 Participants
n=5 Participants
|
975 Participants
n=7 Participants
|
1980 Participants
n=5 Participants
|
|
Region of Enrollment
Netherlands
|
1827 Participants
n=5 Participants
|
1821 Participants
n=7 Participants
|
3648 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 weeksoccurrence of major adverse cardiac events (MACE, i.e. acute myocardial infarction (AMI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG) or death) within 6 weeks after presentation
Outcome measures
| Measure |
Usual Care
n=1827 Participants
usual care was defined as daily practice of the cardiologist or attending emergency doctor, in order to diagnose a patient with chest pain. In this period attending doctors assess the risk of a patient with chest pain, based on his/hers experience and various criteria (for example described in European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, without a formal risk score).
|
HEART Care
n=1821 Participants
HEART care: usual care, complemented by calculation of the HEART score and following the recommended policy.
|
|---|---|---|
|
MACE (Major Adverse Cardiac Events)
|
405 Participants
|
345 Participants
|
SECONDARY outcome
Timeframe: 3 monthsPopulation: Cost-effectiveness analysis was performed in 5 of 9 hospitals
Information on quality of life (QoL) and costs was collected in 5 of the 9 hospitals. Costs for health care resource use were calculated based on Dutch guidelines and cost tables for hospitals. Different costs were used for academic and general hospitals, and costs were adjusted for inflation by using the consumer price indices provided by Statistics Netherlands. For each patient the costs were calculated based on the observed number and type of health care resources used and the type of hospital (academic/general). Data on resource use were collected for each patient in the 5 hospitals; no data were missing. QoL was derived from the EQ-5D-3L questionnaire, consisting of 5 questions (dimensions) with 3 answers each, from which QoL scores (utility values, 0-1, the higher the better) can be directly derived. Quality-adjusted life-years (scale 0-100, higher the better) were calculated over a period of 3 months, based on the estimated QoL values at 0 weeks, 2 weeks, and 3 months.
Outcome measures
| Measure |
Usual Care
n=1176 Participants
usual care was defined as daily practice of the cardiologist or attending emergency doctor, in order to diagnose a patient with chest pain. In this period attending doctors assess the risk of a patient with chest pain, based on his/hers experience and various criteria (for example described in European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, without a formal risk score).
|
HEART Care
n=804 Participants
HEART care: usual care, complemented by calculation of the HEART score and following the recommended policy.
|
|---|---|---|
|
Cost-effectiveness (Costs, QoL, QALYs)
|
0.16 years
Interval 0.16 to 0.17
|
0.17 years
Interval 0.17 to 0.18
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 3 monthswith a women-specific questionnaire, we hope to identify risk factors specific for women (pregnancy diabetes/hypertension, Poly Cystic Ovarial Syndrome (PCOS), etc)
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 weeksTo assess whether the effectiveness and/or safety of using the HEART (history, ecg, age, risk factors, troponin) score (scale 0-10, with higher scores meaning a higher risk on MACEs) is different between specific patient populations, the following pre-specified subgroup analyses will be performed: Age: below and above 62 years of age (median), Gender: Men vs Women, Diabetics vs non-diabetics, Ethnicity: Caucasian vs. other ethnicity. RESULTS: None of the pre-specified subgroup analyses of women, elderly patients, and diabetic patients showed a statistically significantly different effect of HEART care with respect to incidence of MACEs. Ethnicity was unfortunately not possible to analyse due to too much missing data. NB. I am currently not working in the organisation which has the data, and this will not be possible the coming period. Therefore, I cannot provide correct numbers currently on these subgroup analyses, only conclusions. I am sorry for this inconvenience.
Outcome measures
Outcome data not reported
Adverse Events
Usual Care
HEART Care
Serious adverse events
| Measure |
Usual Care
n=1827 participants at risk
usual care was defined as daily practice of the cardiologist or attending emergency doctor, in order to diagnose a patient with chest pain. In this period attending doctors assess the risk of a patient with chest pain, based on his/hers experience and various criteria (for example described in European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, without a formal risk score).
|
HEART Care
n=1821 participants at risk
HEART care: usual care, complemented by calculation of the HEART score and following the recommended policy.
During 14 months, patients presenting with chest pain to the ED of participating hospitals were included in the study. First, all hospitals applied 'usual care' to all patients, i.e. risk assessment and subsequent management without application of the HEART score. Then, during a 14 month period, each 1,5 month 1 randomly allocated hospital sequentially started to apply the HEART score in all chest pain patients (intervention period); during this intervention period patients with a HEART score 0-3 were advised not be admitted to the hospital, and patients with a HEART score above 3 were advised to be treated according to current guidelines.
|
|---|---|---|
|
Cardiac disorders
Cardiac ischemia
|
21.9%
400/1827 • Number of events 400 • 6 weeks
|
18.1%
329/1821 • Number of events 329 • 6 weeks
|
|
Cardiac disorders
Death
|
0.49%
9/1827 • Number of events 9 • 6 weeks
|
0.27%
5/1821 • Number of events 5 • 6 weeks
|
|
Cardiac disorders
Significant stenosis (PCI, CABG, conservative)
|
15.9%
290/1827 • Number of events 290 • 6 weeks
|
13.6%
247/1821 • Number of events 247 • 6 weeks
|
Other adverse events
Adverse event data not reported
Additional Information
Dr. Judith Poldervaart
University Medical Center Utrectht
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place